Thirteen-year experience in lung transplantation for emphysema Stephen D Cassivi, MD, Bryan F Meyers, MD, Richard J Battafarano, MD, Tracey J Guthrie, RN, Elbert P Trulock, MD, John P Lynch, MD, Joel D Cooper, MD, G.Alexander Patterson, MD The Annals of Thoracic Surgery Volume 74, Issue 5, Pages 1663-1670 (November 2002) DOI: 10.1016/S0003-4975(02)04064-X
Fig 1 Lung transplants performed for alpha1 antitrypsin deficiency (Alpha-1), chronic obstructive pulmonary disease (COPD), and all other diagnoses at Washington University in St. Louis by year. The Annals of Thoracic Surgery 2002 74, 1663-1670DOI: (10.1016/S0003-4975(02)04064-X)
Fig 2 Lung transplant actuarial survival by diagnosis. (Alpha-1 = alpha1 antitrypsin deficiency; COPD = chronic obstructive pulmonary disease; Other = lung transplant recipients with other diagnoses.) The Annals of Thoracic Surgery 2002 74, 1663-1670DOI: (10.1016/S0003-4975(02)04064-X)
Fig 3 Actuarial survival of lung transplantation for emphysema by type of procedure (single vs bilateral lung transplantation). The Annals of Thoracic Surgery 2002 74, 1663-1670DOI: (10.1016/S0003-4975(02)04064-X)
Fig 4 Actuarial survival of lung transplantation for emphysema by era (1988 to 1994, 1995 to 2000). The Annals of Thoracic Surgery 2002 74, 1663-1670DOI: (10.1016/S0003-4975(02)04064-X)
Fig 5 Freedom from bronchiolitis obliterans by diagnosis. (Alpha-1 = alpha1 antitrypsin deficiency; COPD = chronic obstructive pulmonary disease.) The Annals of Thoracic Surgery 2002 74, 1663-1670DOI: (10.1016/S0003-4975(02)04064-X)
Fig 6 Freedom from bronchiolitis obliterans by type of procedure (single vs bilateral lung transplantation). The Annals of Thoracic Surgery 2002 74, 1663-1670DOI: (10.1016/S0003-4975(02)04064-X)